These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

287 related articles for article (PubMed ID: 17116831)

  • 1. Livedoid vasculopathy: further evidence for procoagulant pathogenesis.
    Hairston BR; Davis MD; Pittelkow MR; Ahmed I
    Arch Dermatol; 2006 Nov; 142(11):1413-8. PubMed ID: 17116831
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Vasculitis and vasculopathy].
    Marković A
    Acta Med Croatica; 2012 Oct; 66 Suppl 1():19-24. PubMed ID: 23193816
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Livedoid vasculopathy associated with plasminogen activator inhibitor-1 promoter homozygosity (4G/4G) treated successfully with tissue plasminogen activator.
    Deng A; Gocke CD; Hess J; Heyman M; Paltiel M; Gaspari A
    Arch Dermatol; 2006 Nov; 142(11):1466-9. PubMed ID: 17116837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Livedoid vasculopathy (white atrophy) associated with anticardiolipin antibodies].
    Grasland A; Crickx B; Blanc M; Pouchot J; Vinceneux P
    Ann Med Interne (Paris); 2000 Sep; 151(5):408-10. PubMed ID: 11033476
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Livedoid vasculopathy: long-term follow-up results following hyperbaric oxygen therapy.
    Juan WH; Chan YS; Lee JC; Yang LC; Hong HS; Yang CH
    Br J Dermatol; 2006 Feb; 154(2):251-5. PubMed ID: 16433793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A case of livedoid vasculopathy associated with factor V Leiden mutation: successful treatment with oral warfarin.
    Kavala M; Kocaturk E; Zindanci I; Turkoglu Z; Altintas S
    J Dermatolog Treat; 2008; 19(2):121-3. PubMed ID: 18484430
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of thrombophilia determinant factors in patients with livedoid vasculopathy and treatment with anticoagulant drugs--a prospective study.
    Di Giacomo TB; Hussein TP; Souza DG; Criado PR
    J Eur Acad Dermatol Venereol; 2010 Nov; 24(11):1340-6. PubMed ID: 20337814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterozygous prothrombin gene mutation associated with livedoid vasculopathy.
    Anavekar NS; Kelly R
    Australas J Dermatol; 2007 May; 48(2):120-3. PubMed ID: 17535202
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ulcerations caused by livedoid vasculopathy associated with a prothrombotic state: Response to warfarin.
    Davis MD; Wysokinski WE
    J Am Acad Dermatol; 2008 Mar; 58(3):512-5. PubMed ID: 18280355
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Livedoid vasculopathy and its association with factor V Leiden mutation.
    Yong AA; Tan AW; Giam YC; Tang MB
    Singapore Med J; 2012 Dec; 53(12):e258-60. PubMed ID: 23268168
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A case of livedoid vasculopathy in a 22-year-old man.
    Leonard A; Pomeranz MK; Franks AG
    J Drugs Dermatol; 2004; 3(6):678-9. PubMed ID: 15624752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Difficult management of livedoid vasculopathy.
    Francès C; Barete S
    Arch Dermatol; 2004 Aug; 140(8):1011. PubMed ID: 15313824
    [No Abstract]   [Full Text] [Related]  

  • 13. [Recurrent leg ulcers due to livedoid vasculopathy: successful treatment with low-molecular-weight heparin].
    Becker A; Stoffels-Weindorf M; Schimming T; Dissemond J
    Dtsch Med Wochenschr; 2013 Jul; 138(28-29):1458-62. PubMed ID: 23821447
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Livedoid vasculopathy in a patient with factor V mutation (Leiden).
    Biedermann T; Flaig MJ; Sander CA
    J Cutan Pathol; 2000 Sep; 27(8):410-2. PubMed ID: 10955688
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Livedoid vasculopathy.
    Chang D; Patel RM
    Cutis; 2012 Oct; 90(4):179, 181-2. PubMed ID: 23259203
    [No Abstract]   [Full Text] [Related]  

  • 16. ["Idiopathic" white atrophy].
    Tran MD; Bécherel PA; Cordel N; Piette JC; Francès C
    Ann Dermatol Venereol; 2001 Oct; 128(10 Pt 1):1003-7. PubMed ID: 11907958
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Unilateral livedoid vasculopathy associated with involutional phase of cutaneous infantile hemangioma: the connection to coagulation disorders.
    Criado PR; Alavi A; Halpern I; Sotto MN; Kirsner RS
    Int J Low Extrem Wounds; 2013 Dec; 12(4):306-9. PubMed ID: 24043683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Livedoid vasculopathy: A review of pathogenesis and principles of management.
    Vasudevan B; Neema S; Verma R
    Indian J Dermatol Venereol Leprol; 2016; 82(5):478-88. PubMed ID: 27297279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and histopathologic features of 8 patients with microscopic polyangiitis including two with a slowly progressive clinical course.
    Kawakami T; Kawanabe T; Saito C; Kannari M; Mizoguchi M; Nagafuchi H; Okazaki T; Ozaki S; Kimura K; Soma Y
    J Am Acad Dermatol; 2007 Nov; 57(5):840-8. PubMed ID: 17939936
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Livedoid vasculopathy with underlying subcutaneous necrotizing venulitis in an asymptomatic hepatitis B virus carrier: is livedoid vasculopathy a true nonvasculitic disorder?
    Ishibashi M; Miyamoto J; Nagasaka T; Chen KR
    Am J Dermatopathol; 2009 May; 31(3):293-6. PubMed ID: 19384073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.